• All
  • Important
  • Financial Update
  • Fund Raise
  • Board Meeting
  • Dividend/Bonus
  • JV/Acquisition
  • Investor Meet
  • Insider Trade
  • Pledging
  • Others
    ALPHA TRIBE

    Vista Pharmaceuticals Ltd — Board Meeting, 13-02-2026: Board Meeting

    13-02-2026 | 03:26 pm

    Vista Pharma's board approved Q3 & 9-month results. Q3 revenue ₹2.42 Cr, net loss ₹2.32 Cr, impacted by ₹2.05 Cr ECL provision. Company also issued 1.02 Cr warrants, raising ₹3.08 Cr (25% upfront). ₹0.95 Cr statutory dues outstanding.

    No comments yet. Be the first to comment!

    All announcements from Vista Pharmaceuticals Ltd